SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
June 21, 2022
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
1717 Main St
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number,
including area code: (
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange
on which registered
Class A Common Stock, par value $0.0001
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period
complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 21, 2022, Vaxxinity,
Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders
(“Annual Meeting”). A total of 111,968,921 shares of the Company's Class A common stock and 13,874,132
shares of the Company’s Class B common stock were entitled to vote as of April 22, 2022, the record date for
the Annual Meeting, of which 83,301,847 shares of the Company’s Class A common stock and 10,574,388
shares of the Company’s Class B common stock were represented in person or by proxy at the Annual Meeting.
With respect to the matters submitted to a vote of stockholders at the Annual Meeting, holders of Class A
common stock and Class B common stock voted together as a single class, and holders of the Company’s
Class A common stock were entitled to one vote per share and holders of the Company’s Class B common
stock were entitled to ten votes per share.
At the Annual Meeting, the stockholders of the Company voted on the following proposals:
the election of seven nominees, each to serve as a director of the Company until the 2023 Annual
Meeting of Stockholders and until his or her successor is duly elected and qualified;
a proposal to ratify the appointment of Armanino LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2022.
The results of each of the above proposals are discussed further below.
Proposal 1 - Election of Directors
The votes cast for or withheld for each director nominee were as follows:
Mei Mei Hu
Gregory R. Blatt
Accordingly, all nominees listed above were elected to serve as a director of the Company until the 2023
Annual Meeting of Stockholders and until his or her successor is duly elected and qualified.
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm
The voting results with respect to the proposal to ratify the appointment of Armanino LLP to serve as
the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022
were as follows:
Accordingly, the Company’s
stockholders ratified the appointment of Armanino LLP to serve as the
Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
No other matters were submitted to a vote of stockholders at the Annual Meeting.
Item 9.01. Financial Statements and Exhibits.
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
June 24, 2022
/s/ René Paula Molina
Name: René Paula Molina
General Counsel and Secretary